Moderna CEO Stéphane Bancel at #JPM23 (Zachary Brennan for Endpoints News)
January 9, 2023 05:43 PM ESTUpdated January 9, 07:02 PM
Pharma

What we're see­ing at JPM so far: Up­com­ing BD moves, pipeline up­dates and more

Zachary Brennan

Senior Editor

Max Gelman

Senior Editor

SAN FRAN­CIS­CO — Af­ter two years of Covid-stalled vir­tu­al deal­mak­ing, the JP Mor­gan Health­care Con­fer­ence re­turned as an in-per­son event on Mon­day, with plen­ty of ex­cite­ment …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Among phar­ma CEOs, the IRA now and the IRA lat­er get very dif­fer­ent re­ac­tions

Up­dat­ed: With cost-cut­ting un­der­way, Bris­tol My­ers rais­es guid­ance, touts Phase 3 win and scraps an­oth­er

Bris­tol My­ers restarts ra­dio­phar­ma­ceu­ti­cal Phase 3 tri­al, but de­lays read­out by one year

An­drew Left, short sell­er who cam­paigned against Valeant, is ac­cused of fraud by SEC

Eu­ro­pean drug reg­u­la­tor re­jects Alzheimer's drug Leqem­bi, cit­ing safe­ty con­cerns

sponsored

Crit­i­cal Junc­tures in Gene Ther­a­py Clin­i­cal Ma­te­r­i­al Man­u­fac­tur­ing: Where Do I Start? And Will It Work?

A service from the Financial Times